Incremental Value of Transrectal Ultrasound Target Visibility Beyond Clinical and MRI Variables for Predicting Biopsy-Detected Clinically Significant Prostate Cancer: Temporal and External Validation.
PURPOSE To determine whether three-level transrectal ultrasound (TRUS) target visibility adds predictive information beyond clinical and magnetic resonance imaging (MRI) variables for patient-level biopsy-detected clinically significant prostate cancer (csPCa). MATERIALS AND METHODS This retrospective two-center stud...